ImmunoPrecise Antibodies Ltd.

IPA51

Penny Stock

$0.67arrow_drop_down1.47%-$0.01

Penny Stock

IPA51

$0.67

arrow_drop_down1.47%-$0.01

Penny Stock

Performance History

Key Stats
Open	$0.65
Prev. Close	$0.64
EPS	-0.79
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$18.70M
PE Ratio	-

	LOW	HIGH
Day Range	0.62	0.67
52 Week Range	0.53	2.60

Ratios

Revenue	-





EPS	-0.79

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About ImmunoPrecise Antibodies Ltd. (IPA)

The ImmunoPrecise Antibodies Ltd. (IPA) stock price history reflects the performance of the company's stock over a period of time. It provides valuable information about the stock's movement and trends. Investors can use this data to analyze and make informed decisions about buying or selling IPA shares. By studying the stock price history, investors can identify patterns or trends that may indicate potential future price movements.

The ImmunoPrecise Antibodies Ltd., IPA stock quote represents the current market price of the company's stock. It provides real-time information about the stock's value and allows investors to track its performance on a daily basis. Traders and investors use stock quotes to determine the best time to buy or sell IPA shares. The stock quote also includes bid and ask prices, which indicate the prices at which buyers are willing to buy and sellers are willing to sell the stock.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Jennifer Lynne Bath Ph.D.
Headquarters: Victoria
Employees: 102
Exchange: NASDAQ

add ImmunoPrecise Antibodies Ltd. to watchlist

Keep an eye on ImmunoPrecise Antibodies Ltd.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is ImmunoPrecise Antibodies Ltd.'s (IPA) price per share?

The current price per share for ImmunoPrecise Antibodies Ltd. (IPA) is $0.67. The stock has seen a price change of -$0.01 recently, indicating a -1.47% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for ImmunoPrecise Antibodies Ltd. (IPA)?

For ImmunoPrecise Antibodies Ltd. (IPA), the 52-week high is $2.6, which is 288.06% from the current price. The 52-week low is $0.53, the current price is 26.42% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is ImmunoPrecise Antibodies Ltd. (IPA) a growth stock?

ImmunoPrecise Antibodies Ltd. (IPA) has shown an average price growth of 0.41% over the past three years. It has received a score of 7 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying ImmunoPrecise Antibodies Ltd. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is ImmunoPrecise Antibodies Ltd. (IPA) stock price performance year to date (YTD)?

As of the latest data, ImmunoPrecise Antibodies Ltd. (IPA) has a year-to-date price change of -60.59%. Over the past month, the stock has experienced a price change of -15.54%. Over the last three months, the change has been -33.33%. Over the past six months, the figure is -55.92%.

help

Is ImmunoPrecise Antibodies Ltd. (IPA) a profitable company?

ImmunoPrecise Antibodies Ltd. (IPA) has a net income of -$27.18M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 49.16% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -86.23% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 18.65%, providing insight into the company's sales performance and growth. The gross profit is $12.05M. Operating income is noted at -$13.74M. Furthermore, the EBITDA is -$8.57M.

help

What is the market capitalization of ImmunoPrecise Antibodies Ltd. (IPA)?

ImmunoPrecise Antibodies Ltd. (IPA) has a market capitalization of $18.14M. The average daily trading volume is 338.37K, indicating the stock's liquidity and investor engagement.